Clinical Trials Browser

OTHER × Interventional × Bronchiolitis Obliterans Syndrome × Clear all

NCT06271616 2025-12-26

Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Phase 2 Recruiting

Bronchiolitis Obliterans Syndrome

NCT02388048 2025-01-29

Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic Leukemia

Phase 2 Completed

LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06279585 2024-02-28

Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD

Phase NA Unknown

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Motor Activity, Hematologic Neoplasms

NCT05413356 2022-10-19

Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome

Phase 2 Unknown

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

NCT04118075 2021-05-21

PT-CY With or Without Low-dose ATG for Lymphoid Malignancies Undergoing Allo-HSCT

Phase 2 Completed

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease

NCT02638467 2020-11-05

Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy

Phase 2 Completed

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia

NCT04043676 2019-08-02

Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid Leukemia

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01240525 2019-02-12

ProT4

Phase 2 Unknown

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile

NCT00038597 2018-10-30

Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)

Phase 2 Completed

MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT01334060 2018-09-07

WIN

Phase 2 Completed

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Myeloid, Acute

NCT02286063 2018-06-26

AmbOx

Phase 4 Completed

Bronchiolitis Obliterans Syndrome, Disease, Leiomyoma

NCT01460693 2018-04-24

SPIRIT2

Phase 3 Completed

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Myeloid, Chronic-Phase

NCT01343173 2018-03-13

STIM 2

Phase NA Completed

MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01815346 2018-01-12

Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG

Phase 1/2 Terminated

Bronchiolitis Obliterans Syndrome, Breast Neoplasms

NCT01600053 2016-12-15

Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia

Phase 2 Terminated

11 enrolled 4 charts

LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00280241 2016-02-04

Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia

Phase 2 Completed

65 enrolled 8 charts

LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01373983 2014-12-30

ZicBol

Phase 4 Completed

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Neuralgia, Peripheral Nervous System Diseases, Wounds and Injuries

NCT00379587 2014-03-19

Rituximab for Prevention of Chronic GVHD

Phase 1/2 Completed

65 enrolled 9 charts

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

NCT01819389 2014-01-07

Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance

Phase 3 Completed

MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00478985 2013-07-02

STIM

Phase NA Completed

MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00144430 2009-02-03

Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children

Phase 2 Completed

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Leukemia